A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Project: Research

Project Details

StatusActive
Effective start/end date12/05/23 → 11/05/25

Keywords

  • Clinical Trials
  • Focal-Onset Seizures